PARGY-LAD
From Wikipedia, the free encyclopedia
|
PARGY-LAD
|
|
| Systematic (IUPAC) name | |
| (6aR,9R)-N,N-diethyl-7-propynyl-4,6,6a,7,8,9- hexahydroindolo-[4,3-fg]quinoline-9-carboxamide |
|
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C22H25N3O |
| Mol. mass | 347.46 g/mol |
| Synonyms | PARGY-LAD, 6-propynyl-6-nor-Lysergic acid diethylamide |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
PARGY-LAD, also known as 6-propynyl-6-nor-lysergic acid diethylamide is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PARGY-LAD is a hallucinogenic drug similar to LSD, but is slightly less potent than LSD with a dose of 160 micrograms producing only mild effects, and 500 micrograms required for full activity.
|
|||||

